Study Identifies a Potential Treatment for Obesity-Linked Breathing Disorder
April 17, 2025
April 17, 2025
WASHINGTON, April 17 -- George Washington University posted the following news:
* * *
Study Identifies a Potential Treatment for Obesity-Linked Breathing Disorder
Researchers from the George Washington University have uncovered promising evidence in an animal study that shows setmelanotide, an FDA-approved medication for a rare genetic obesity disorder, may offer a pathway for treating a life-threatening form of sleep-disordered breathing called Obesity Hyp . . .
* * *
Study Identifies a Potential Treatment for Obesity-Linked Breathing Disorder
Researchers from the George Washington University have uncovered promising evidence in an animal study that shows setmelanotide, an FDA-approved medication for a rare genetic obesity disorder, may offer a pathway for treating a life-threatening form of sleep-disordered breathing called Obesity Hyp . . .